sy-5007
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 23, 2021 (NCT05278364)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06352190 | Phase 1 | May 1, 2024 | Government of China |
| NCT06325761 | Phase 1 | Apr 1, 2024 | Government of China |
| NCT06332053 | Phase 1 | Apr 1, 2024 | Government of China |
| NCT06031558 | Phase 3 | Jun 20, 2023 | Government of China |
| NCT05278364 | Phase 1 | Apr 23, 2021 | Government of China |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 5 | 5 | 2 | 2021 |
1 organizations
Page 1 / 1